Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

FENC Fennec Pharmaceuticals Inc

7,19

0,07 (0,98%)

23 Mai 2024 - Fermé

Retardé de 15 minutes

Form EFFECT - Notice of Effectiveness

Fennec Pharmaceuticals (NASDAQ:FENC)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024

Plus de graphiques de la Bourse Fennec Pharmaceuticals

Fennec Pharmaceuticals (NASDAQ:FENC)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024

Plus de graphiques de la Bourse Fennec Pharmaceuticals

Actualités Fennec Pharmaceuticals Inc

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 21 Mai 2024 ( il y a 1 jour) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 21 Mai 2024 ( il y a 1 jour) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 21 Mai 2024 ( il y a 1 jour) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mardi 14 Mai 2024 ( il y a 1 semaine) • Edgar (US Regulatory)

Fennec Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update
Mardi 14 Mai 2024 ( il y a 1 semaine) • GlobeNewswire Inc.

Form DEF 14A - Other definitive proxy statements
Lundi 13 Mai 2024 ( il y a 1 semaine) • Edgar (US Regulatory)

Fennec Pharmaceuticals to Report First Quarter 2024 Financial Results on May 14, 2024
Mercredi 8 Mai 2024 ( il y a 2 semaines) • GlobeNewswire Inc.

Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update
Jeudi 21 Mars 2024 ( il y a 2 mois) • GlobeNewswire Inc.

Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024
Mardi 19 Mars 2024 ( il y a 2 mois) • GlobeNewswire Inc.

Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
Lundi 18 Mars 2024 ( il y a 2 mois) • PR Newswire (US)

Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
Lundi 18 Mars 2024 ( il y a 2 mois) • GlobeNewswire Inc.

Form 8-K/A - Current report: [Amend]
Mercredi 6 Mars 2024 ( il y a 3 mois) • Edgar (US Regulatory)

Plus d'articles sur Fennec Pharmaceuticals Inc

Capital Group Di

Gravitas Education

Xtr MSCI Canada ESG Scre...

Valens Groworks

Abercrombie & Fitch

Dimensional Us Marketwid...

Freshlocal Solutions (CE)

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales